This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
34.—(1) Only the provisions of the Act specified in Schedule 5, instruments made under those provisions and any other provision of the Act which relates to those provisions shall apply in relation to products to which these Regulations apply, and those provisions and instruments shall apply in relation to those products as if they were medicinal products to which the Act applies (whether or not they would otherwise be so).
(2) It shall be a duty of the Commission to consider any matter referred to them by the Ministers in accordance with the provisions of regulation 11(1) and Schedule 2, and to report their findings and advice in connection with any such matter, and their reasons for giving such advice, to the Ministers.
(3) It shall be a duty of the Board to consider any matter referred to them by the Ministers in accordance with the provisions of regulation 11(1) and Schedule 2, and to report their findings and advice in connection with any such matter, and their reasons for giving such advice, to the Ministers.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
